Login/Sign Up
Adroglare Injection 1 ml
₹12.2*
MRP ₹13.5
10% off
₹11.47*
MRP ₹13.5
15% CB
₹2.03 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Adroglare Injection 1 ml belongs to a class of medicines called 'sympathomimetic', primarily used for the treatment of cardiac arrest, hypotension due to septic shock and life-threatening allergic reactions. Cardiac arrest is a sudden loss of blood flow resulting from the failure of the heart to pump effectively. Severe allergic reactions, including anaphylaxis due to foods, drugs, insect stings, bites, or other allergens. It may cause symptoms like breathing difficulty, facial swelling, dizziness, confusion and hives.
Adroglare Injection 1 ml contains 'adrenaline', also called epinephrine. Adroglare Injection 1 ml is used to increase blood flow to the heart and increase the chance of restoring a heartbeat in cardiac arrest. Adroglare Injection 1 ml increases mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is also used to increase blood flow through veins by constricting blood vessels and helps to relax the muscles, which block the airways and allow breathing to return to normal in allergic reactions due to foods, drugs, insect stings or bites or any other allergens.
Adroglare Injection 1 ml is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Adroglare Injection 1 ml may cause common side effects like increased heart rate, difficulty breathing, blurred vision, headache, dizziness, mood or mental changes, and an increase in blood pressure. If these side effects persist, consult your doctor immediately.
Adroglare Injection 1 ml should not be taken if you are allergic to it. Inform your doctor if you are using any medicines other than Adroglare Injection 1 ml. Inform your doctor if you are a pregnant/breastfeeding woman. Do not use Adroglare Injection 1 ml if the solution is discoloured. Adroglare Injection 1 ml should be used with caution in brain disorders, pheochromocytoma (tumour on adrenal gland), pulmonary oedema, kidney impairment, liver impairment, hypertension, hyperthyroidism, diabetes mellitus, and narrow-angle glaucoma.
Adroglare Injection 1 ml contains 'adrenaline'; it is also called epinephrine. It belongs to a class of medicines called 'sympathomimetic', primarily taken for the treatment of cardiac arrest, hypotension due to septic shock and life-threatening allergic reactions. Adroglare Injection 1 ml works by increasing blood flow to the heart and also increases the chance of restoring a heartbeat in cardiac arrest. Adroglare Injection 1 ml increases mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is also used to increase blood flow through veins by constricting blood vessels and helps to relax the muscles, which block the airways and allow breathing to return to normal in allergic reactions due to foods, drugs, insect stings or bites or any other allergens. Adroglare Injection 1 ml is also used in the treatment of bradycardia(slow heart rate), mydriasis( dilation of the pupil of the eye) and acute asthma.
Adroglare Injection 1 ml should not be taken if you are allergic to it. Inform your doctor if you are using any medicines other than Adroglare Injection 1 ml. Inform your doctor if you are a pregnant/breastfeeding woman. Adroglare Injection 1 ml should be used with caution in brain disorders, pheochromocytoma (tumour on adrenal gland), pulmonary oedema, kidney impairment, hypertension, and liver impairment. Adroglare Injection 1 ml is not recommended for diabetes, Parkinson's disease, hyperthyroidism, narrow-angle glaucoma and cardiovascular diseases. Adroglare Injection 1 ml is for emergency use only, and medical supervision of the patients is necessary after administration.
Drug-Drug Interaction: Adroglare Injection 1 ml may have interactions with anti-depressants (imipramine, amitriptyline), anti-cancer (Procarbazine), beta-blockers (propranolol), sympathomimetic agents (Oxytocin), alpha-blockers (phentolamine), adrenergic neuron blockers (guanethidine), bronchodilators (aminophylline, theophylline), anti-diabetic drugs (insulin), antihistamines (diphenhydramine), selective MAO inhibitors (linezolid), cardiac-glycosides (digoxin).
Drug-Food Interaction: Adroglare Injection 1 ml may interact with alcohol.
Drug-Disease Interaction: Adroglare Injection 1 ml is contraindicated in cardiovascular disorders, diabetes, Parkinson's disease, brain disorders, pulmonary oedema, kidney impairment, liver impairment, hypertension, narrow-angle glaucoma, pheochromocytoma (tumour on adrenal gland), diabetes or hyperthyroidism.
Cardiac arrest: Cardiac arrest is the abrupt loss of heart function, breathing and consciousness. The condition usually results from a problem with your heart's electrical system, which disrupts your heart's pumping action and stops blood flow to your body. Symptoms include sudden collapse, pulselessness, no breathing, and loss of consciousness.
Hypotension associated with septic shock: Dilated blood vessels may significantly decrease blood flow to certain organs or may result in a significant drop in blood pressure, leading to a state known as septic shock.
Life-threatening allergic reactions: Severe allergic reactions, including anaphylaxis due to foods, drugs, insect stings or bites or any other allergens. Symptoms include pain, redness, swelling (in the area of sting and sometimes beyond), flushing, hives, itching, and a potentially life-threatening reaction that may impair breathing and cause the body to go into shock.
Alcohol
Caution
Avoid or limit consumption of alcohol while on treatment with Adroglare Injection 1 ml.
Pregnancy
Caution
Adroglare Injection 1 ml is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
Breast Feeding
Caution
Adroglare Injection 1 ml is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
Driving
Caution
After receiving this medicine, do not drive or operate machines which need high concentration as it may cause dizziness.
Liver
Caution
Adroglare Injection 1 ml should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Depending on the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required.
Kidney
Caution
Adroglare Injection 1 ml should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
Children
Caution
Adroglare Injection 1 ml may be used in children, but dose adjustments should be made by the doctor based on the height and weight of the child. So please consult your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
Product Substitutes